AGARWALEYE vs MEDANTA: Stock Comparison
GLOBAL HEALTH is the larger company by market capitalisation. DR AGARWALS HEALTH CARE L shows lower leverage, while GLOBAL HEALTH shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AGARWALEYE leads 2; MEDANTA leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AGARWALEYE | MEDANTA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | AGARWALEYE | MEDANTA |
|---|---|---|
| Live Price | ₹488.2 | ₹1,299.9 |
| Day Change | -0.1% | 0.02% |
| Volume | 1,322 | 1,381 |
| 52-Week High | ₹567.75 | ₹1,544 |
| 52-Week Low | ₹401 | ₹956 |
| Distance from 52W High | -14.01% | -15.81% |
Valuation
| Metric | AGARWALEYE | MEDANTA |
|---|---|---|
| Market Cap | ₹15,504 Cr | ₹35,056 Cr |
| P/E Ratio | 104.05x | 62.54x |
| P/B Ratio | 7.63x | 8.78x |
| EPS | ₹4.65 | ₹5.9 |
| Book Value | ₹63.93 | ₹148.18 |
| Dividend Yield | 0% | 0.04% |
Growth
| Metric | AGARWALEYE | MEDANTA |
|---|---|---|
| Revenue Growth (TTM YoY) | 22.6% | 24.5% |
| EPS Growth (TTM YoY) | 20.8% | 42% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | AGARWALEYE | MEDANTA |
|---|---|---|
| ROE | 7.93% | 13.91% |
| ROCE | 10.49% | 11.9% |
| Net Margin | 6.4% | 12.62% |
| Operating Margin | 16.3% | 18.01% |
| Debt to Equity | 0.07x | 0.3x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | AGARWALEYE | MEDANTA |
|---|---|---|
| Promoter Holding | 32.33%▼ 0.01 pp | 33% |
| FII Holding | 49.56%▼ 8.4 pp | 9.91%▲ 0.45 pp |
| DII Holding | 15.87%▲ 8.15 pp | 17.01%▲ 0.12 pp |
| Public Holding | 2.24%▲ 0.26 pp | 39.97%▼ 0.59 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR AGARWALS HEALTH CARE L and GLOBAL HEALTH.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.